Novartis in the News: Blockbuster Heart Failure Drug Entresto Approved, Pricing Questions Remain; $3.4 Billion Kickback Allegations Loom Read more
AstraZeneca and Cephalon Agree to Pay $46.5 Million and $7.5 Million, Respectively, for Allegedly Underpaying Rebates Owed Under Medicaid Drug Rebate Program Read more